Please use this identifier to cite or link to this item:
|Title:||Antituberculosis activity of the antimalaria cytochrome bcc oxidase inhibitor SCR0911||Authors:||Chong, Sherilyn Shi Min
Manimekalai, Malathy Sony Subramanian
Sarathy, Jickky Palmae
Williams, Zoe C.
Harold, Liam K.
Cook, Gregory M.
Bates, Roderick Wayland
|Issue Date:||2020||Source:||Chong, S. S. M., Manimekalai, M. S. S., Sarathy, J. P., Williams, Z. C., Harold, L. K., Cook, G. M., . . . Grüber, G. (2020). Antituberculosis activity of the antimalaria cytochrome bcc oxidase inhibitor SCR0911. ACS Infectious Diseases, 6(4), 725-737. doi:10.1021/acsinfecdis.9b00408||Journal:||ACS Infectious Diseases||Abstract:||The ability to respire and generate adenosine triphosphate (ATP) is essential for the physiology, persistence, and pathogenicity of Mycobacterium tuberculosis, which causes tuberculosis. By employing a lead repurposing strategy, the malarial cytochrome bc1 inhibitor SCR0911 was tested against mycobacteria. Docking studies were carried out to reveal potential binding and to understand the binding interactions with the target, cytochrome bcc. Whole-cell-based and in vitro assays demonstrated the potency of SCR0911 by inhibiting cell growth and ATP synthesis in both the fast- and slow-growing M. smegmatis and M. bovis bacillus Calmette–Guérin, respectively. The variety of biochemical assays and the use of a cytochrome bcc deficient mutant strain validated the cytochrome bcc oxidase as the direct target of the drug. The data demonstrate the broad-spectrum activity of SCR0911 and open the door for structure–activity relationship studies to improve the potency of new mycobacteria specific SCR0911 analogues.||URI:||https://hdl.handle.net/10356/138832||ISSN:||2373-8227||DOI:||10.1021/acsinfecdis.9b00408||Rights:||This document is the Accepted Manuscript version of a Published Work that appeared in final form in ACS Infectious Diseases, copyright © American Chemical Society after peer review and technical editing by the publisher. To access the final edited and published work see https://doi.org/10.1021/acsinfecdis.9b00408||Fulltext Permission:||embargo_20210417||Fulltext Availability:||With Fulltext|
|Appears in Collections:||SBS Journal Articles|
Files in This Item:
|935.84 kB||Adobe PDF||Under embargo until Apr 17, 2021|
checked on Oct 21, 2020
Items in DR-NTU are protected by copyright, with all rights reserved, unless otherwise indicated.